<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Macrophagic myofasciitis on SciBook: analysis of published information about vaccinations and infections</title>
    <link>https://mrascii.github.io/scibook/en/diseases/macrophagic-myofasciitis/</link>
    <description>Recent content in Macrophagic myofasciitis on SciBook: analysis of published information about vaccinations and infections</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <copyright>© amantonio, scibook.org 2017–2019</copyright>
    
	<atom:link href="https://mrascii.github.io/scibook/en/diseases/macrophagic-myofasciitis/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Macrophagic myofasciitis: characterization and pathophysiology</title>
      <link>https://mrascii.github.io/scibook/en/content/vaccines/aluminium/012-macrophagic-myofasciitis-characterization-and-pathophysiology/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>https://mrascii.github.io/scibook/en/content/vaccines/aluminium/012-macrophagic-myofasciitis-characterization-and-pathophysiology/</guid>
      <description>A review article about Macrophagic myofasciitis (MMF). In some patients, the aluminum adjuvants do not dissolve after the vaccination, but rather remain at the injection site and form an aluminum granuloma. Accompanying symptoms are usually myalgia (muscle pains), chronic fatigue, cognitive impairment, as well as various autoimmune diseases.</description>
    </item>
    
  </channel>
</rss>